Imexon

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

Imexon
Clinical data
ATC code
  • none
Identifiers
  • 4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.056.199
Chemical and physical data
FormulaC4H5N3O
Molar mass111.104 g·mol−1
3D model (JSmol)
  • O=C1/N=C(/N)C2N1C2
  • InChI=1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8) ☒N
  • Key:BIXBBIPTYBJTRY-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References
  • Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

Public Domain This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.